Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Facial Pain

2-amino-5-phosphonovalerate has been researched along with Facial Pain in 2 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, DK1
Jung, CY1
Lee, HJ1
Choi, HS1
Ju, JS1
Bae, YC1
Lam, DK1
Sessle, BJ1
Cairns, BE1
Hu, JW1

Other Studies

2 other studies available for 2-amino-5-phosphonovalerate and Facial Pain

ArticleYear
Peripheral glutamate receptors participate in interleukin-1beta-induced mechanical allodynia in the orofacial area of rats.
    Neuroscience letters, 2004, Mar-11, Volume: 357, Issue:3

    Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Excitatory Amino Acid Antagonists; Facial Pa

2004
Peripheral NMDA receptor modulation of jaw muscle electromyographic activity induced by capsaicin injection into the temporomandibular joint of rats.
    Brain research, 2005, Jun-07, Volume: 1046, Issue:1-2

    Topics: Analysis of Variance; Animals; Capsaicin; Disease Models, Animal; Dizocilpine Maleate; Electromyogra

2005